Below are the top 10 Micro Cap stocks with highest upside potential, based on
the difference between current price and Wall Street analysts average target
price. One Chinese company (CIS) is on the list. YRC Worldwide Inc.
(NASDAQ:YRCW) has the 1st highest upside potential in this segment of the
market. Its upside is 873.5%. Its consensus target price is $0.55 based on the
average of all estimates. Neostem Inc. (AMEX:NBS) has the 2nd highest upside
potential in this segment of the market. Its upside is 480.3%. Its consensus
target price is $3.56 based on the average of all estimates. Anooraq Resources
Corporation (USA) (AMEX:ANO) has the 3rd highest upside potential in this
segment of the market. Its upside is 453.7%. Its consensus target price is $2.99
based on the average of all estimates. NuPathe Inc (NASDAQ:PATH) has the 4th
highest upside potential in this segment of the market. Its upside is 449.5%.
Its consensus target price is $12.58 based on the average of all estimates. The
PMI Group, Inc. (NYSE:PMI) has the 5th highest upside potential in this segment
of the market. Its upside is 387.6%. Its consensus target price is $1.50 based
on the average of all estimates. Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) has
the 6th highest upside potential in this segment of the market. Its upside is
372.0%. Its consensus target price is $6.75 based on the average of all
estimates. Camelot Information Systems Inc (ADR) (NYSE:CIS) has the 7th highest
upside potential in this segment of the market. Its upside is 348.8%. Its
consensus target price is $14.36 based on the average of all estimates.
Cytokinetics, Inc. (NASDAQ:CYTK) has the 8th highest upside potential in this
segment of the market. Its upside is 346.4%. Its consensus target price is $5.00
based on the average of all estimates. Zalicus, Inc. (NASDAQ:ZLCS) has the 9th
highest upside potential in this segment of the market. Its upside is 315.8%.
Its consensus target price is $4.20 based on the average of all estimates. AVI
BioPharma, Inc. (NASDAQ:AVII) has the 10th highest upside potential in this
segment of the market. Its upside is 293.9%. Its consensus target price is $3.67
based on the average of all estimates.
No comments:
Post a Comment